NYSE:HAEMedical Equipment
A Look At Haemonetics (HAE) Valuation After Recent Share Price Weakness
Recent share performance and business snapshot
Haemonetics (HAE) shares have retreated over the past 3 months, with the price closing at $55.93 and total return showing declines over the week, month, past 3 months, year and year to date.
The Boston based medical technology company generates US$1.32b in revenue and US$175.44m in net income, with operations spanning plasma collection systems, hospital hemostasis analyzers, blood recovery products and vascular closure devices.
See our latest...